Shimizu, Japan

Takeshi Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Watanabe. Retrieved from https://idiyas.com/inventor/takeshi-watanabe-or1ml2lx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeshi Watanabe

Introduction

Takeshi Watanabe is a notable inventor based in Shimizu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. His work focuses on innovative solutions for treating cachexia and related conditions.

Latest Patents

Watanabe holds a patent for glycookadaic acid, which includes processes for its preparation and methods for its use. This invention provides a means to treat and prevent cachexia and side effects caused by TNF. The pharmaceutical compositions he developed utilize glycookadaic acid as an active component, showcasing his commitment to advancing medical treatments.

Career Highlights

Watanabe is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in research and development. His work has led to advancements in pharmaceutical applications, particularly in the treatment of conditions that significantly impact patient quality of life.

Collaborations

Some of his notable coworkers include Daisuke Uemura and Toshihiro Yamamoto. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Takeshi Watanabe's innovative work in pharmaceuticals exemplifies the impact of dedicated research on healthcare solutions. His contributions continue to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…